OBJECTIVE:
Response to erectile dysfunction (ED) treatment has typically been reported over a three-month period in a number of pharmaceutical trials. Little is known about the factors associated with response to treatment over a longer period. The current study examines predictors associated with response to treatment at 12 months in a group of men enrolled in an ED disease registry study. METHODS: Clinical information was collected at baseline and HRQOL data was collected at baseline, 3, 6, and 12-months. Eighty-nine men reported receiving ED treatment while enrolled in the study and completed the 12-month HRQOL questionnaire. Scores on the IIEF erectile functioning scale at baseline and 12-months were compared. Men who reported a 4-point or greater improvement were considered treatment responders (N = 40). Forty-nine men were classified as non-responders. A multivariate logistic regression model predicting treatment response at 12 months and controlling for age and baseline erectile functioning was specified. RESULTS: Men who were treatment responders at the 12-month follow-up were significantly more likely at baseline to have a partner who encourages sex (OR = 4.230, p = .0369), be unmarried (OR = 0.05, p = .0020), report greater rigidity during sex (OR = 4.814, p = .0288), and have more frequent morning erections (OR = 4.360, p = .0432). CONCLUSIONS: Long-term response to ED treatment is significantly associated with baseline erectile functioning (as measured by frequency of morning erections and penile rigidity during sex) and the supportiveness of a partner. Practitioners can use this information to guide patient expectations for treatment outcomes and to recommend other treatment if relationship concerns are present. Urinary problems secondary to benign prostatic hyperplasia (BPH) are found in 20 to 25% of the population of men over 50 years of age. This is thus a public health problem with a number of diagnostic, therapeutic and economic facets. The severity of the problem is assessed by the score obtained on the IPSS, a well-known and recognised questionnaire. OBJECTIVE: As part of the growing importance attached to the care giver, it is interesting to evaluate the consequences of this masculine pathology for the spouse. METHOD: As part of a cohort study, the GP gave the patient 2 Urinary problems secondary to benign prostatic hyperplasia (BPH) are found in 20 to 25% of the population of men over 50 years of age. This is thus a public health problem with a number of diagnostic, therapeutic and economic facets. The severity of the problem is assessed by the score obtained on the IPSS, a well-known and recognised questionnaire. OBJECTIVE: As part of the growing importance attached to the caregiver, it is interesting to evaluate the consequences of this masculine pathology for the spouse. METHOD: As part of a cohort study, the GP gave the patient 2 PFM (Patient Family Measurement) self-questionnaires for himself and his spouse. For the analysis, 357 patient questionnaires and 316 spouse questionnaires were used. The rate of return of the spouse questionnaires (88%) was very satisfactory. The quality of life (QOL) of the patient was measured by SF12; the results consisted of 2 scores: mental (MCS-12) and physical (PCS-12). The norm observed in the American population, and from which the scores were standardised, was 50. In the patient where the QOL had deteriorated, all the scores were lower than this norm, (PCS-12 = 46 & MCS-12 = 47.2). This deterioration in the quality of life also applied to the spouse. (PCS-12 = 44.4 & MCS-12 = 45.9). For the PCS-12, the difference was significant. CONCLUSION: The rate of return of the spouse questionnaires showed the interest and involvement of spouses in their husband's pathology. The deterioration in the quality of life of the spouse highlighted the impact of the disease on those around him. In both the patient and the spouse, the quality of life deteriorated with the severity of the BPH.
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